Canada markets close in 2 hours 4 minutes

MRNA Jan 2025 95.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
4.0000+0.3500 (+9.59%)
As of 12:54PM EDT. Market open.
Full screen
Previous Close3.6500
Open4.0000
Bid3.7500
Ask4.0500
Strike95.00
Expire Date2025-01-17
Day's Range4.0000 - 4.0000
Contract RangeN/A
Volume2
Open Interest3.25k
  • Yahoo Finance Video

    FDA considers updating COVID boosters, Novavax stock reacts

    The US Food and Drug Administration (FDA) is set to vote on recommendations for updated COVID-19 booster shots as the KP.2 variant strain begins to spread across the US. Yahoo Finance Health Reporter Anjalee Khemlani joins Market Domination to discuss the impact this is having on vaccine makers, particularly Novavax (NVAX), whose stock has shot up in Monday's session. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.

  • Zacks

    FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains

    An FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to target the WHO-recommended JN.1 variant or the KP.2 variant which is the currently dominating strain in the country.

  • Zacks

    Company News for June 4, 2024

    Companies In The Article Are:NVDA, MRK,MRNA, SPOT, SRCL and WM